Gilead Sciences
GILD
GILD
1,520 hedge funds and large institutions have $72.7B invested in Gilead Sciences in 2018 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 544 increasing their positions, 724 reducing their positions, and 107 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,520
Holders Change
-41
Holders Change %
-2.63%
% of All Funds
34.85%
Holding in Top 10
47
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-21.67%
% of All Funds
1.08%
New
76
Increased
544
Reduced
724
Closed
107
Calls
$1.25B
Puts
$1.82B
Net Calls
-$567M
Net Calls Change
-$452M
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$998M |
| 2 |
Bank of New York Mellon
New York
|
+$229M |
| 3 |
N
Natixis
Paris,
France
|
+$133M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$121M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$120M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$362M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$298M |
| 3 |
Goldman Sachs
New York
|
-$244M |
| 4 |
Renaissance Technologies
New York
|
-$162M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$125M |
